CLNN logo

Clene (CLNN) Company Overview

Profile

Full Name:

Clene Inc.

Country:

United States

IPO:

October 18, 2018

Indexes:

Not included

Description:

Clene is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases. They use a unique approach to create treatments that target the underlying causes of these conditions, aiming to improve patients' quality of life and advance medical science.

Key Details

Price

$4.27

Annual Revenue

$654.00 K(+38.27% YoY)

Annual EPS

-$9.40(-2.17% YoY)

Annual ROE

-595.47%

Beta

0.82

Events Calendar

Earnings

Next earnings date:

Mar 13, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 13, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 11, 2024

Analyst ratings

Recent major analysts updates

Feb 25, 25 HC Wainwright & Co.
Buy
Feb 25, 25 D. Boral Capital
Buy
Feb 6, 25 D. Boral Capital
Buy
Dec 19, 24 D. Boral Capital
Buy
Dec 10, 24 D. Boral Capital
Buy
Nov 22, 24 Benchmark
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Nov 14, 24 Canaccord Genuity
Buy
Nov 13, 24 D. Boral Capital
Buy
Oct 24, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Clene?
  • Does Clene pay dividends?
  • What sector is Clene in?
  • What industry is Clene in?
  • What country is Clene based in?
  • When did Clene go public?
  • Is Clene in the S&P 500?
  • Is Clene in the NASDAQ 100?
  • Is Clene in the Dow Jones?
  • When was Clene's last earnings report?
  • When does Clene report earnings?
  • Should I buy Clene stock now?

What is the ticker symbol for Clene?

The ticker symbol for Clene is NASDAQ:CLNN

Does Clene pay dividends?

No, Clene does not pay dividends

What sector is Clene in?

Clene is in the Consumer Defensive sector

What industry is Clene in?

Clene is in the Packaged Foods industry

What country is Clene based in?

Clene is headquartered in United States

When did Clene go public?

Clene's initial public offering (IPO) was on October 18, 2018

Is Clene in the S&P 500?

No, Clene is not included in the S&P 500 index

Is Clene in the NASDAQ 100?

No, Clene is not included in the NASDAQ 100 index

Is Clene in the Dow Jones?

No, Clene is not included in the Dow Jones index

When was Clene's last earnings report?

Clene's most recent earnings report was on Nov 13, 2024

When does Clene report earnings?

The next expected earnings date for Clene is Mar 13, 2025

Should I buy Clene stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions